
### [MONDO:0016869](http://purl.obolibrary.org/obo/MONDO_0016869)
**Label:** partial deletion of chromosome 4

**Subclasses:** [MONDO:0016886](http://purl.obolibrary.org/obo/MONDO_0016886) (partial deletion of the short arm of chromosome 4), [MONDO:0008684](http://purl.obolibrary.org/obo/MONDO_0008684) (wolf-Hirschhorn syndrome), [MONDO:0019895](http://purl.obolibrary.org/obo/MONDO_0019895) (distal monosomy 4q), [MONDO:0016903](http://purl.obolibrary.org/obo/MONDO_0016903) (partial deletion of the long arm of chromosome 4), [MONDO:0013292](http://purl.obolibrary.org/obo/MONDO_0013292) (chromosome 4q21 deletion syndrome), 

**Mapped go classes:** [GO:0003290](http://purl.obolibrary.org/obo/GO_0003290) (atrial septum secundum morphogenesis), [GO:0021678](http://purl.obolibrary.org/obo/GO_0021678) (third ventricle development), [GO:0003179](http://purl.obolibrary.org/obo/GO_0003179) (heart valve morphogenesis), [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0006836](http://purl.obolibrary.org/obo/GO_0006836) (neurotransmitter transport), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0043195](http://purl.obolibrary.org/obo/GO_0043195) (terminal bouton), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0070201](http://purl.obolibrary.org/obo/GO_0070201) (regulation of establishment of protein localization), [GO:0030267](http://purl.obolibrary.org/obo/GO_0030267) (glyoxylate reductase (NADP) activity), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0019905](http://purl.obolibrary.org/obo/GO_0019905) (syntaxin binding), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0006851](http://purl.obolibrary.org/obo/GO_0006851) (mitochondrial calcium ion transmembrane transport), [GO:0044291](http://purl.obolibrary.org/obo/GO_0044291) (cell-cell contact zone), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0021670](http://purl.obolibrary.org/obo/GO_0021670) (lateral ventricle development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0070032](http://purl.obolibrary.org/obo/GO_0070032) (synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex), [GO:0017053](http://purl.obolibrary.org/obo/GO_0017053) (transcriptional repressor complex), [GO:0098742](http://purl.obolibrary.org/obo/GO_0098742) (cell-cell adhesion via plasma-membrane adhesion molecules), [GO:0018024](http://purl.obolibrary.org/obo/GO_0018024) (histone-lysine N-methyltransferase activity), [GO:0034214](http://purl.obolibrary.org/obo/GO_0034214) (protein hexamerization), [GO:0030133](http://purl.obolibrary.org/obo/GO_0030133) (transport vesicle), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0099093](http://purl.obolibrary.org/obo/GO_0099093) (mitochondrial calcium release), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0005326](http://purl.obolibrary.org/obo/GO_0005326) (neurotransmitter transporter activity), [GO:0003149](http://purl.obolibrary.org/obo/GO_0003149) (membranous septum morphogenesis), [GO:0030007](http://purl.obolibrary.org/obo/GO_0030007) (cellular potassium ion homeostasis), [GO:0098793](http://purl.obolibrary.org/obo/GO_0098793) (presynapse), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0099526](http://purl.obolibrary.org/obo/GO_0099526) (presynapse to nucleus signaling pathway), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0016079](http://purl.obolibrary.org/obo/GO_0016079) (synaptic vesicle exocytosis), [GO:0015369](http://purl.obolibrary.org/obo/GO_0015369) (calcium:proton antiporter activity), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0016618](http://purl.obolibrary.org/obo/GO_0016618) (hydroxypyruvate reductase activity), [GO:0060539](http://purl.obolibrary.org/obo/GO_0060539) (diaphragm development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0048706](http://purl.obolibrary.org/obo/GO_0048706) (embryonic skeletal system development), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0003289](http://purl.obolibrary.org/obo/GO_0003289) (atrial septum primum morphogenesis), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0043022](http://purl.obolibrary.org/obo/GO_0043022) (ribosome binding), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0048794](http://purl.obolibrary.org/obo/GO_0048794) (swim bladder development), [GO:0031201](http://purl.obolibrary.org/obo/GO_0031201) (SNARE complex), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0040037](http://purl.obolibrary.org/obo/GO_0040037) (negative regulation of fibroblast growth factor receptor signaling pathway), [GO:0015992](http://purl.obolibrary.org/obo/GO_0015992) (proton transport), [GO:0030073](http://purl.obolibrary.org/obo/GO_0030073) (insulin secretion), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0006887](http://purl.obolibrary.org/obo/GO_0006887) (exocytosis), [GO:0050872](http://purl.obolibrary.org/obo/GO_0050872) (white fat cell differentiation), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0051560](http://purl.obolibrary.org/obo/GO_0051560) (mitochondrial calcium ion homeostasis), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0010452](http://purl.obolibrary.org/obo/GO_0010452) (histone H3-K36 methylation), [GO:0051204](http://purl.obolibrary.org/obo/GO_0051204) (protein insertion into mitochondrial membrane), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0000149](http://purl.obolibrary.org/obo/GO_0000149) (SNARE binding), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0048298](http://purl.obolibrary.org/obo/GO_0048298) (positive regulation of isotype switching to IgA isotypes), [GO:0021592](http://purl.obolibrary.org/obo/GO_0021592) (fourth ventricle development), [GO:0017134](http://purl.obolibrary.org/obo/GO_0017134) (fibroblast growth factor binding), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0035067](http://purl.obolibrary.org/obo/GO_0035067) (negative regulation of histone acetylation), [GO:2001032](http://purl.obolibrary.org/obo/GO_2001032) (regulation of double-strand break repair via nonhomologous end joining), [GO:0015297](http://purl.obolibrary.org/obo/GO_0015297) (antiporter activity), [GO:0034770](http://purl.obolibrary.org/obo/GO_0034770) (histone H4-K20 methylation), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0001571](http://purl.obolibrary.org/obo/GO_0001571) (non-tyrosine kinase fibroblast growth factor receptor activity), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0042407](http://purl.obolibrary.org/obo/GO_0042407) (cristae formation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0090241](http://purl.obolibrary.org/obo/GO_0090241) (negative regulation of histone H4 acetylation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0006875](http://purl.obolibrary.org/obo/GO_0006875) (cellular metal ion homeostasis), [GO:1903758](http://purl.obolibrary.org/obo/GO_1903758) (negative regulation of transcription from RNA polymerase II promoter by histone modification), [GO:0097034](http://purl.obolibrary.org/obo/GO_0097034) (mitochondrial respiratory chain complex IV biogenesis), [GO:0097033](http://purl.obolibrary.org/obo/GO_0097033) (mitochondrial respiratory chain complex III biogenesis), [GO:0070491](http://purl.obolibrary.org/obo/GO_0070491) (repressing transcription factor binding), [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis), [GO:0070131](http://purl.obolibrary.org/obo/GO_0070131) (positive regulation of mitochondrial translation), [GO:0017075](http://purl.obolibrary.org/obo/GO_0017075) (syntaxin-1 binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), 

**Class expressions from DL-Learner:**

- Thing 53.50%
- [GO:0070032](http://purl.obolibrary.org/obo/GO_0070032) (synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex) 51.67%
- [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body) 51.67%
- [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body) 51.67%
- [GO:0031201](http://purl.obolibrary.org/obo/GO_0031201) (SNARE complex) 51.67%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 51.67%
- [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane) 51.67%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 51.67%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 51.67%
- [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity) 51.67%
- [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity) 51.67%
- [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity) 51.67%
- [GO:0001571](http://purl.obolibrary.org/obo/GO_0001571) (non-tyrosine kinase fibroblast growth factor receptor activity) 51.67%
- [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) 51.67%
- [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity) 51.67%


